{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:48:50Z","timestamp":1775044130483,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32200150"],"award-info":[{"award-number":["32200150"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974474"],"award-info":[{"award-number":["81974474"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203926"],"award-info":[{"award-number":["82203926"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["WX21B38"],"award-info":[{"award-number":["WX21B38"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.intimp.2023.110577","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T03:45:56Z","timestamp":1691552756000},"page":"110577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Comparing four immunosuppressive agents for chronic spontaneous urticaria-A network meta-analysis"],"prefix":"10.1016","volume":"123","author":[{"given":"Wang","family":"Bei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qu","family":"Zilu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Kai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Ruili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Liuqing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.110577_b0005","doi-asserted-by":"crossref","unstructured":"M. Maurer, K. Weller, C. Bindslev-Jensen, A. Gim\u00e9nez-Arnau, P.J. Bousquet, J. Bousquet, G.W. Canonica, M.K. Church, K.V. Godse, C.E.H. Grattan, M.W. Greaves, M. Hide, D. Kalogeromitros, A.P Kaplan, S.S. Saini, X.J Zhu, T. Zuberbier. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report. Allergy. Mar;66(3) (2011)317-30.","DOI":"10.1111\/j.1398-9995.2010.02496.x"},{"key":"10.1016\/j.intimp.2023.110577_b0010","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2340\/00015555-1109","article-title":"High Prevalence of Mental Disorders and Emotional Distress in Patients with Chronic Spontaneous Urticaria","volume":"91","author":"Staubach","year":"2011","journal-title":"Acta. Derm. Venereol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110577_b0015","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier","year":"2022","journal-title":"Allergy."},{"key":"10.1016\/j.intimp.2023.110577_b0020","doi-asserted-by":"crossref","unstructured":"C. Dressler, S. Rosumeck, R.N. Werner, M. Magerl, M. Metz, M. Maurer, A. Nast, T. Zuberbier Executive summary of the methods report for 'The EAACI\/GA2 LEN\/EDF\/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update'. Allergy. May;73(5) (2018)1145-1146.","DOI":"10.1111\/all.13414"},{"key":"10.1016\/j.intimp.2023.110577_b0025","unstructured":"Urticaria Research Center of the Chinese Society of Medicine, Division of Dermatology and Venereology. Guidelines for the treatment of urticaria in China (2018 edition). Chinese J. Dermatol., 52(1) (2019)5."},{"issue":"1","key":"10.1016\/j.intimp.2023.110577_b0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/jdv.13357","article-title":"Unmet medical needs for chronic spontaneous urticaria patients: highlighting the real-life clinical practice in Taiwan","volume":"30","author":"Cho","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110577_b0035","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/1744666X.2017.1249467","article-title":"Therapy of antihistamine-resistant chronic spontaneous urticaria","volume":"13","author":"Greiwe","year":"2017","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110577_b0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/jamadermatol.2018.3447","article-title":"Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of \u201cReal-world\u201d Evidence","volume":"155","author":"Tharp","year":"2019","journal-title":"JAMA. Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110577_b0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.iac.2013.09.012","article-title":"Chronic spontaneous urticaria: etiology and pathogenesis","volume":"34","author":"Saini","year":"2014","journal-title":"Immunol. Allergy. Clin. North. Am."},{"issue":"1","key":"10.1016\/j.intimp.2023.110577_b0050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jdermsci.2017.03.009","article-title":"Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria","volume":"87","author":"Hide","year":"2017","journal-title":"J. Dermatol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.110577_b0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/jid.2014.306","article-title":"Efficacy and safety of omalizumab in patients with chronic idiopathic\/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study","volume":"135","author":"Saini","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110577_b0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2013.05.013","article-title":"Omalizumab in patients with symptomatic chronic idiopathic\/spontaneous urticaria despite standard combination therapy","volume":"132","author":"Kaplan","year":"2013","journal-title":"J. Allergy. Clin. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2023.110577_b0065","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1215372","article-title":"Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria","volume":"368","author":"Maurer","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.110577_b0070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaip.2019.07.021","article-title":"How to Treat Patients with Chronic Spontaneous Urticaria with Omalizumab: Questions and Answers","volume":"8","author":"T\u00fcrk","year":"2020","journal-title":"J. Allergy. Clin. Immunol. Pract."},{"issue":"15","key":"10.1016\/j.intimp.2023.110577_b0075","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA."},{"issue":"6","key":"10.1016\/j.intimp.2023.110577_b0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s40257-013-0047-3","article-title":"Treatment of refractory chronic urticaria: current and future therapeutic options","volume":"14","author":"Asero","year":"2013","journal-title":"Am. J. Clin. Dermatol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110577_b0085","first-page":"157","article-title":"Taking advantage of the explosion of systematic reviews: an efficient MEDLINE search strategy","volume":"4","author":"Shojania","year":"2001","journal-title":"Eff. Clin. Pract."},{"issue":"apr03 1","key":"10.1016\/j.intimp.2023.110577_b0090","doi-asserted-by":"crossref","first-page":"b1147","DOI":"10.1136\/bmj.b1147","article-title":"Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews","volume":"338","author":"Song","year":"2009","journal-title":"BMJ."},{"issue":"7387","key":"10.1016\/j.intimp.2023.110577_b0095","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/bmj.326.7387.472","article-title":"Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses","volume":"326","author":"Song","year":"2003","journal-title":"BMJ."},{"key":"10.1016\/j.intimp.2023.110577_b0100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1471-2288-12-138","article-title":"Simulation evaluation of statistical properties of methods for indirect and mixed treatment comparisons","volume":"12","author":"Song","year":"2012","journal-title":"BMC. Med. Res. Methodol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110577_b0105","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/sim.5539","article-title":"Extending methods for investigating the relationship between treatment effect and baseline risk from pairwise meta-analysis to network meta-analysis","volume":"32","author":"Achana","year":"2013","journal-title":"Stat. Med."},{"issue":"16","key":"10.1016\/j.intimp.2023.110577_b0110","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/sim.1201","article-title":"Network meta-analysis for indirect treatment comparisons","volume":"21","author":"Lumley","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.intimp.2023.110577_b0115","first-page":"119","article-title":"To evaluate the efficacy and safety of ebastine combined with Tripterygium glycosides in the treatment of CSU","volume":"18","author":"Zhang","year":"2021","journal-title":"North. Pharm"},{"key":"10.1016\/j.intimp.2023.110577_b0120","first-page":"9","article-title":"Effect of ebastine combined with Tripterygium glycosides in the treatment of CSU","volume":"14","author":"Wu","year":"2016","journal-title":"Chin. and. Foreign. Med. Research"},{"key":"10.1016\/j.intimp.2023.110577_b0125","first-page":"145","article-title":"Efficacy analysis of Tripterygium glycosides combined with second-generation H1 antihistamines in the treatment of CSU","volume":"19","author":"Zhang","year":"2021","journal-title":"Contemporary. Med. Forum"},{"key":"10.1016\/j.intimp.2023.110577_b0130","first-page":"3302","article-title":"Effect observation of fexofenadine combined with Tripterygium glycosides in treating chronic urticaria","author":"Chen","year":"2014","journal-title":"Chongqing. J. Med"},{"issue":"4","key":"10.1016\/j.intimp.2023.110577_b0135","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaad.2006.04.078","article-title":"Neo-I-30 Study Group. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial","volume":"55","author":"Vena","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110577_b0140","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4103\/0378-6323.129382","article-title":"A randomized placebo-controlled double-blind pilot study of methotrexate in the treatment of H1 antihistamine-resistant chronic spontaneous urticaria","volume":"80","author":"Sharma","year":"2014","journal-title":"Indian. J. Dermatol. Venereol. Leprol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110577_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2019.100033","article-title":"Comparing azathioprine with cyclosporine in the treatment of antihistamine refractory chronic spontaneous urticaria: A randomized prospective active-controlled non-inferiority study","volume":"12","author":"Pathania","year":"2019","journal-title":"World. Allergy. Organ. J."},{"key":"10.1016\/j.intimp.2023.110577_b0150","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/sj.bjp.0707002","article-title":"Role of calcineurin in the regulation of human lung mast cell and basophil function by cyclosporine and FK506","volume":"150","author":"Harrison","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110577_b0155","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2133.2000.03664.x","article-title":"Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria","volume":"143","author":"Grattan","year":"2000","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110577_b0160","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jaip.2017.07.017","article-title":"Cyclosporine for Chronic Spontaneous Urticaria: A Meta-Analysis and Systematic Review","volume":"6","author":"Kulthanan","year":"2018","journal-title":"J. Allergy. Clin. Immunol. Pract."},{"issue":"3","key":"10.1016\/j.intimp.2023.110577_b0165","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/ijd.12536","article-title":"Azathioprine as a therapeutic alternative for refractory chronic urticaria","volume":"54","author":"Tal","year":"2015","journal-title":"Int. J. Dermatol."},{"issue":"04","key":"10.1016\/j.intimp.2023.110577_b0170","first-page":"370","article-title":"Mechanism of action and dermatological Applications of Tripterygium glycosides","volume":"38","author":"Bai","year":"2021","journal-title":"Dermatological. Bulletin"},{"issue":"11","key":"10.1016\/j.intimp.2023.110577_b0175","first-page":"1763","article-title":"Triptolide inhibits the differentiation of Th17 cells induced by inflammatory monocytes [J]","volume":"31","author":"He","year":"2015","journal-title":"The. J. Pract. Med"},{"issue":"21","key":"10.1016\/j.intimp.2023.110577_b0180","first-page":"4102","article-title":"Effects and mechanisms of multi-glycoside of Tripterygium wilfordii improving glomerular inflammatory injury by regulating p38MAPK signaling activation in diabetic nephropathy rats","volume":"39","author":"Huang","year":"2014","journal-title":"Chin. J. Chin. Mater. Med."},{"issue":"5","key":"10.1016\/j.intimp.2023.110577_b0185","first-page":"37","article-title":"Study on the pharmacological effects and hepatotoxicity mechanism of Tripterygium glycosides","volume":"33","author":"Fu","year":"2020","journal-title":"J. Med. Inform."},{"issue":"31","key":"10.1016\/j.intimp.2023.110577_b0190","first-page":"1347","article-title":"Effect of triptolide on IL-23\/Th17(IL-17) inflammatory axis in asthmatic BALB\/c mice","volume":"1356","author":"Yang","year":"2015","journal-title":"Chin. J. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923009037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923009037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:21:09Z","timestamp":1736432469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923009037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":38,"alternative-id":["S1567576923009037"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110577","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing four immunosuppressive agents for chronic spontaneous urticaria-A network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110577","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110577"}}